Clinical response to imatinib mesylate in recurrent and metastatic gastrointestinal stromal tumors

被引：0
|
作者：
Villalobos, R. [1 ]
Hernandez, G. [1 ]
Martinez-Prieto, M. [1 ]
Silva, A. [1 ]
机构：
[1] UMAE Hosp Oncol CMN Siglo XXI, Mexico City, DF, Mexico
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
20528
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Sprouty4A, a novel genetic marker of response to imatinib mesylate in gastrointestinal stromal tumors (GIST)
    Arnoletti, JP
    Pan, ZZ
    Fletcher, J
    Favorova, O
    Von Mehren, M
    Eisenberg, BL
    Godwin, AK
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) : S8 - S8
  • [22] IGFBP3 induces apoptosis in gastrointestinal stromal tumors but does not mediate response to imatinib mesylate
    Dupart, Jheri
    Trent, Jonathan
    Lee, Ho-Young
    Chiao, Paul
    Godwin, Andrew
    Zhang, Wei
    CANCER RESEARCH, 2009, 69
  • [23] Gastrointestinal Stromal Tumors Treated with Imatinib Mesylate: Apparent Diffusion Coefficient in the Evaluation of Therapy Response in Patients
    Tang, Lei
    Zhang, Xiao-Peng
    Sun, Ying-Shi
    Shen, Lin
    Li, Jian
    Qi, Li-Ping
    Cui, Yong
    RADIOLOGY, 2011, 258 (03) : 729 - 738
  • [24] Assessment of gastrointestinal stromal tumors with computed tomography following treatment with imatinib mesylate
    Sith Phongkitkarun
    Cholada Phaisanphrukkun
    Janjira Jatchavala
    Ekaphop Sirachainan
    World Journal of Gastroenterology, 2008, (06) : 892 - 898
  • [25] Giant Gastrointestinal Stromal Tumor with Remarkable Preoperative Response to Imatinib Mesylate
    Stokes, Allen
    Herndon, Mark D.
    Conforti, Arnold M.
    AMERICAN SURGEON, 2010, 76 (08) : 903 - 904
  • [26] Assessment of gastrointestinal stromal tumors with computed tomography following treatment with imatinib mesylate
    Phongkitkarun, Sith
    Phaisanphrukkun, Cholada
    Jatchavala, Janjira
    Sirachainan, Ekaphop
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (06) : 892 - 898
  • [27] Treatment of localized anorectal gastrointestinal stromal tumors with preoperative imatinib mesylate therapy
    Wang, W.
    Luo, S.
    Chen, W.
    Kang, L.
    Deng, Y.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S412 - S412
  • [28] Imatinib mesylate therapy in patients with gastrointestinal stromal tumors and impaired liver function
    Bauer, S
    Hagen, V
    Pielken, HJ
    Bojko, P
    Seeber, S
    Schütte, J
    ANTI-CANCER DRUGS, 2002, 13 (08) : 847 - 849
  • [29] Imatinib Mesylate: Past Successes and Future Challenges in the Treatment of Gastrointestinal Stromal Tumors
    Ksienski, Doran
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2011, 5 : 365 - 379
  • [30] Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor
    Rink, Lori
    Skorobogatko, Yuliya
    Kossenkov, Andrew
    Belinsky, Martin
    Pajak, Thomas
    von Mehren, Margaret
    Ochs, Michael
    Eisenberg, Burton
    Godwin, Andrew
    CANCER RESEARCH, 2009, 69
12345